Order Article Reprints

Jensen C, Sinkeviciute D, Madsen DH, Önnerfjord P, Hansen M, Schmidt H, Karsdal MA, Svane IM, Willumsen N. Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade. Cancers. 2020; 12(10):2786. https://doi.org/10.3390/cancers12102786

Jensen, Christina, Dovile Sinkeviciute, Daniel Hargbøl Madsen, Patrik Önnerfjord, Morten Hansen, Henrik Schmidt, Morten Asser Karsdal, Inge Marie Svane, and Nicholas Willumsen. 2020. "Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade" Cancers 12, no. 10: 2786. https://doi.org/10.3390/cancers12102786

Jensen, C., Sinkeviciute, D., Madsen, D. H., Önnerfjord, P., Hansen, M., Schmidt, H., Karsdal, M. A., Svane, I. M., & Willumsen, N. (2020). Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade. Cancers, 12(10), 2786. https://doi.org/10.3390/cancers12102786